| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 113787-92-1 | N-[3-[(Methoxycarbonyl)dithio]-N-[[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenoxy]acetyl]-L-alanyl]-D-valine | C20H23F3N4O7S2 |
| 113789-43-8 | 1'-(1'-Thio-4'-Methylcyclohexane)Acetic Acid-Oxytocin | C49H75N11O12S2 |
| 113789-44-9 | 1'-(1'-Methyl-4'-Thiopiperidine)Acetic Acid-Oxytocin | C48H74N12O12S2 |
| 113789-91-6 | 3-Allyl-2-Pyrrolidinone | C7H11NO |
| 113793-31-0 | (2S,3R)-3-Hydroxy-2-{[(4-Methoxyphenyl)Sulfonyl]Amino}Butanoic Acid | C11H14NO6S |
| 113794-23-3 | 1-Octynyltributylstannane | C20H40Sn |
| 113798-74-6 | 2,3,6-Trifluorophenol | C6H3F3O |
| 113798-80-4 | (R)-1,4-Dioxaspiro[4.5]decane-2-methanol | C9H16O3 |
| 113802-15-6 | (6E)-1-Methyl-6-(2-Methylpropylidene)-2,5-Piperazinedione | C9H14N2O2 |
| 113805-71-3 | Olopatadine Methyl Ester | C22H25NO3 |
| 113806-01-2 | Olopatadine Methyl Ester | C22H25NO3 |
| 113806-03-4 | Olopatadine Impurity 34 | C23H27NO3 |
| 113806-05-6 | Olopatadine | C21H23NO3 |
| 113806-06-7 | (11E)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid | C21H23NO3 |
| 113806-28-3 | (2R,4S)-3-Benzoyl-4-Methyl-2-Phenyl-1,3-Oxazolidin-5-One | C17H15NO3 |
| 113806-36-3 | Ethyl [(2R,4S)-3-Benzoyl-4-Methyl-5-Oxo-2-Phenyl-1,3-Oxazolidin-4-Yl]Acetate | C21H21NO5 |
| 113808-03-0 | Picrasidine T | C28H25N4O4 |
| 113808-19-8 | N-(7-Hydroxy-4-methyl-2-oxo-2H-1-benzopyran-6-yl)hexadecanamide Sodium Salt | C26H38NNaO4 |
| 113808-86-9 | 3,5-Dimethyl-1H-pyrazole-4-carboxylic acid | C6H8N2O2 |
| 113811-42-0 | 2-[[4-[(2,4-Diaminopteridin-6-Yl)Methylamino]Benzoyl]Amino]-3-Phosphono-Propanoic Acid | C17H19N8O6P |
| 113811-44-2 | 2-[[4-[(2,4-Diaminopteridin-6-Yl)Methylamino]Benzoyl]Amino]-6-Phosphono-Hexanoic Acid | C20H25N8O6P |
| 113811-51-1 | 3-[[4-[(2,4-Diaminopteridin-6-Yl)Methyl-Methyl-Amino]Benzoyl]Amino]Propyl-Ethoxy-Phosphinic Acid | C20H27N8O4P |
| 113812-15-0 | N1,N4-Bis[3-(Ethylamino)Propyl]-1,4-Butanediamine Hydrochloride (1:4) | C14H38Cl4N4 |
| 113812-31-0 | 1-(1-Phenylcyclohexyl)-2,3-Dihydro-4-Pyridone | C17H21NO |
| 113813-79-9 | Perimed | C6H11I2NO3 |
| 113816-36-7 | Methyl 2-Bromo-3,3,3-Trifluoropropanoate | C4H4BrF3O2 |
| 113817-55-3 | 4-Bromo-N,N-Dimethyl-2,2-Diphenylbutanamide | C18H20BrNO |
| 113817-63-3 | 1-O-Heptadecylglycerol | C20H42O3 |
| 113817-64-4 | Goniothalamicin | C35H64O7 |
| 113822-11-0 | Dimethyl(N,N,N',N'-tetramethylethylene-1,2-diamine)palladium(II) | C8H22N2Pd |
| 113823-56-6 | 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl 4-Methylbenzenesulfonate | C17H11F17O3S |
| 113823-66-8 | Carbobenzoxyphenylalanylarginyldiazomethane | C24H29N7O4 |
| 113824-17-2 | (2E,4E)-5-(5-Methyl-1,2-Oxazol-3-Yl)-2,4-Pentadien-1-Ol | C9H11NO2 |
| 113824-18-3 | (2E,4E)-5-(5-Methyl-1,2-Oxazol-3-Yl)-2,4-Pentadienal | C9H9NO2 |
| 113825-05-1 | N-(2,2-Diethoxyethyl)-2-Thiophenemethanamine | C11H19NO2S |
| 113825-16-4 | 4-Methyl-1H-imidazole-2-carbaldehyde | C5H6N2O |
| 113825-55-1 | 1-Isothiocyanato-4-[(trans,trans)-4'-pentyl[1,1'-bicyclohexyl]-4-yl]benzene | C24H35NS |
| 113826-06-5 | (2R)-(-)-Glycidyl tosylate | C10H12O4S |
| 113826-44-1 | Cefoperazone dihydrate | C25H27N9O8S2.2(H2O) |
| 113826-87-2 | 3-Methyl-5-Phenyl-4-Isoxazolemethanol | C11H11NO2 |
| 113828-61-8 | S-2-Pyridinyl-D-Cysteine | C8H10N2O2S |
| 113828-85-6 | N-[(1S)-2-Cyclohexyl-1-(Hydroxymethyl)Ethyl]-Carbamic Acid Phenylmethyl Ester | |
| 113829-10-0 | (9Z)-9-Octadecenoic Acid 1,1'-[1-[[(1-Oxooctadecyl)Oxy]Methyl]-1,2-Ethanediyl] Ester | C57H106O6 |
| 113833-54-8 | 4-Hydroxy-3-[2-[4-[[[3-[[2-(Sulfooxy)Ethyl]Sulfonyl]Phenyl]Amino]Carbonyl]Phenyl]Diazenyl]-1-Naphthalenesulfonate Sodium Salt (1:2) | C25H20N3Na2O11S3 |
| 113835-76-0 | Olopatadine Methanol | C21H25NO2 |
| 113835-92-0 | N-Desmethyl Olopatadine | C20H21NO3 |
| 113836-66-1 | 2-(3-Methylbutanoyl)Hydrazinecarbothioamide | C6H13N3OS |
| 113840-08-7 | N,N-Diethyl-N-Methylethanaminium Methyl Carbonate | C9H21NO3 |
| 113841-59-1 | 4-(Bromomethyl)-3-methyl-5-phenylisoxazole | C11H10BrNO |
| 113841-82-0 | Ethyl 5-Cyclohexyl-3-Methyl-1,2-Oxazole-4-Carboxylate | C13H19NO3 |